Oralni anabolicki steroidi

9 Pùvodní práce 19. Gasche Y, Daali Y, Fathi M, Chiappe A, Cottini S, Dayer P, Desmeules J. Codeine intoxication associated with ultrarapid CYP2D6 metabolism. N Engl J Med 2004; 351(27): Jankù I. Farmakokinetické základy dávkování lékù. Praha: Avicenum 1986, Johnson RE, Fudala PJ, Payne R. Buprenorphine: considerations for pain management. J Pain Symptom Manage, 2005; 29(3): Kršiak M.: Novinky ve farmakologii opioidù. In: Kozák J, v léèbì bolesti. Praha: Mladá Fronta ., 2009: Thompson CM, Wojno H, Greiner E, May EL, Rice KC, Selley DE. Activation of G-proteins by morphine and codeine congeners:insights to the relevance of O-and N-demethylated metabolites at mu- and delta-opioid receptors. J Pharmacol Exp Ther 2004; 308(2): Witter E, Kern SE. Role of morphine s metabolites in analgesia: concepts and controversies. AAPS J 2006; 8(2): Zhou SF. Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4. Curr Drug Metab 2008;9(4): Latta KS, Ginsberg B, Barkin RL. Meperidine: a critical review. Am J Ther 2002; 9(1): Lalovic B, Kharasch E, Hoffer C, Risler L, Liu-Chen LY, Shen DD. Pharmacokinetics and pharmacodynamic of oral oxycodone in healthy human subjects: role of circulating active metabolites. Clin Pharmacol Ther 2006; 79(5): Seifert CF, Kennedy S. Meperidine is alive and well in the new millenium: evaluation of meperidine usage and frequency of averse drug reactions. Pharmacotherapy, 2004;24(6): Slanar O, Nobilis M, Kvetina J, Idle JR, Perlík F. CYP2D6 polymorphism, tramadol pharmacokinetics and pupillary response. Eur J Clin Pharmacol 2006; 62(1): PharmDr. Milada Halaèová, . Oddìlení klinické farmacie NNH Roentgenova Praha 5 Do redakce pøišlo: K publikaci pøijato: BOLEST ROÈNÍK ÈÍSLO 4

Oralni anabolicki steroidi

oralni anabolicki steroidi

Media:



http://buy-steroids.org